Creative Financial Designs’s Zevra Therapeutics ZVRA Stock Holding History

Creative Financial Designs’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$803	Hold	56	–	–	﹤0.01%	2072
2026 Q1	$522	Hold	56	–	–	﹤0.01%	1999
2025 Q4	$502	Hold	56	–	–	﹤0.01%	1910
2025 Q3	$533	Hold	56	–	–	﹤0.01%	1915
2025 Q2	$493	Hold	56	–	–	﹤0.01%	1891
2025 Q1	$419	Hold	56	–	–	﹤0.01%	1928
2024 Q4	$467	Hold	56	–	–	﹤0.01%	1737
2024 Q3	$389	Hold	56	–	–	﹤0.01%	1631
2024 Q2	$274	Hold	56	–	–	﹤0.01%	1600
2024 Q1	$325	Hold	56	–	–	﹤0.01%	1611
2023 Q4	$367	Hold	56	–	–	﹤0.01%	1549
2023 Q3	$270	Buy	+56	New	+$280	﹤0.01%	1459
2023 Q1	–	Sell	-56	Closed	-$257	–	1437
2022 Q4	$257	Hold	56	–	–	﹤0.01%	1264
2022 Q3	$0	Hold	56	–	–	﹤0.01%	1347
2022 Q2	$0	Hold	56	–	–	﹤0.01%	1357
2022 Q1	$0	Hold	56	–	–	﹤0.01%	1343
2021 Q4	$0	Hold	56	–	–	﹤0.01%	1467
2021 Q3	$1K	Buy	+56	New	+$564	﹤0.01%	1380

Other funds holding ZVRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Creative Financial Designs's ZVRA Position: Q2 2026 in Review

Creative Financial Designs held its Zevra Therapeutics (ZVRA) position steady in Q2 2026 at 56 shares worth $803. The position accounts for ﹤0.01% of the portfolio, ranked #2072.

Creative Financial Designs first reported a position in ZVRA in Q3 2021 and has held it in 18 quarters since. The position peaked at $1K in Q3 2021. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

Creative Financial Designs held 56 shares of Zevra Therapeutics worth $803 as of Q2 2026.
Creative Financial Designs left its Zevra Therapeutics share count unchanged in Q2 2026.
Zevra Therapeutics made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #2072 holding.
Creative Financial Designs first reported a position in Zevra Therapeutics in Q3 2021 and has held it in 18 quarters since.
Creative Financial Designs's Zevra Therapeutics position peaked at $1K in Q3 2021.
157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.